Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A long-term, follow-up of the immunogenicity and safety of GlaxoSmithKline Biologicals’ novel HPV vaccine in healthy female subjects vaccinated in the primary study
Human Papillomavirus Types 16 and 18 Vaccine
108052
NCT00359619
Infections, Papillomavirus
Phase 2
 
The results of this study 108052 are summarised with studies 102115 and 107919 on the GSK Clinical Study Register. An annotated case report form is not available for this study. A blank case report form will be provided. A reporting and analysis plan is not available for this study.
March 2014

Powered by ideaPoint, Inc.